Article

Neuroprotection researchers describe important progress in their field

Since a first symposium on neuroprotection was held at the Associationfor Research in Vision and Ophthalmology (ARVO) meeting 5 years ago, therehave been significant advances in understanding about the mechanisms fordeath of retinal neurons and in the development of neuroprotective therapiesfor glaucoma and other neurodegenerative diseases. At the 2004 annual ARVOmeeting, a panel of leading researchers provided an update on that progressin a symposium entitled "Neuroprotection: Where Are We Now".

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.